Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.03 USD
Change Today 0.00 / 0.00%
Volume 0.0
REON On Other Exchanges
As of 4:30 PM 05/8/15 All times are local (Market data is delayed by at least 15 minutes).

resolute oncology inc (REON) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/15/14 - $0.06
52 Week Low
02/26/15 - $0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RESOLUTE ONCOLOGY INC (REON)

Related News

No related news articles were found.

resolute oncology inc (REON) Related Businessweek News

No Related Businessweek News Found

resolute oncology inc (REON) Details

Resolute Oncology Inc., a development stage company, focusing on pharmaceutical business. The company sells cancer products in Germany. It also has rights to develop and commercialize Pegylated Granulocyte Colony-Stimulating Factor, a biosimilar therapeutic protein product under a license agreement with Reliance Life Sciences Limited. The company was formerly known as Pequot Resources, Inc. and changed its name to Resolute Oncology Inc. in January 2013. Resolute Oncology Inc. was incorporated in 2009 and is based in Sherman Oaks, California.

resolute oncology inc (REON) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

resolute oncology inc (REON) Key Developments

Resolute Oncology Files Form 15

Resolute Oncology Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock, par value $0.001 par value under the Securities Exchange Act of 1934, as amended.

Resolute Oncology Inc.’s Common Stock To Be Deleted From OTCBB

Resolute Oncology Inc.’s common stock will be deleted from OTC Bulletin Board (OTCBB) effective May 20, 2014 due to regulatory/non compliance.

Resolute Oncology Inc. will Change its Ticker to REON.E from REON

Effective April 21, 2014, Resolute Oncology Inc. will change its OTC Bulletin Board stock ticker symbol to REON.E from REON.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REON:US $0.03 USD 0.00

REON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for REON.
View Industry Companies

Industry Analysis


Industry Average

Valuation REON Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESOLUTE ONCOLOGY INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at